Global Fund has allocated about N1.16 trillion ($790 million) for HIV, tuberculosis (TB), malaria and health systems strengthening in Nigeria for 2027-2029 implementation period.
The Guardian learnt that the Federal Government was expected to provide 15 per cent counterparts funding in addition to the GC7 co-financing commitments.
Meanwhile, the Global Fund has called on the Nigerian government to ensure that there is no interruption in funding for Tuberculosis, warning that the country risks reversal of all the progress made in the fight against the infectious disease if enough domestic funding is not made available for the TB control.
It noted that, with sustained investment, strengthened healthcare systems, and continued innovation, Nigeria could end TB as a public health concern.
Global Fund Team Lead in Nigeria, Jean-Thomas Nouboussi, who made the call at the official launch of Lenacapavir (LEN) PrEP for HIV prevention, and the unveiling of the Multisectoral Accountability Framework for TB (MAF-TB) application in Abuja, noted that Nigeria had achieved very impressive results in the fight against TB, stressing that treatment coverage increased from 100,000 cases in 2019 to 458 cases in 2025.
According to him, Lenacapavir represents not only a game-changer but a major advance in the prevention of HIV, as it addresses one of the key challenges in the prevention of HIV, which was the difficulty of adherence to a daily HIV regimen.
In his remarks, the Minister of State for Health and Social Welfare, Dr Adekunle Salako, said Nigeria’s TB response had achieved a historic milestone with case notification surging from 130,591 in 2020 to 440,000 in 2025, the highest ever recorded in Nigeria.
He attributed the achievement to the strategic expansion of diagnostic networks, especially the gene expert network.
